Search Login Register

temsirolimus Summary

Description: structure in first source; inhibits mTOR protein

Also Known As: CCI 779; CCI-779; Torisel; Wyeth brand of temsirolimus

Networked: 571 relevant articles (81 outcomes, 197 trials/studies) for this Drug

Key Diseases for which temsirolimus is Relevant

  1. Renal Cell Carcinoma (Grawitz Tumor) : 36 outcomes 43 studies in 185 results
  2. Neoplasms (Cancer) : 22 outcomes 74 studies in 206 results
  3. Kidney Neoplasms (Kidney Cancer) : 8 outcomes 8 studies in 33 results
  4. Squamous Cell Carcinoma (Epidermoid Carcinoma) : 4 outcomes 4 studies in 8 results
  5. Carcinoma (Carcinomatosis) : 3 outcomes 4 studies in 22 results
Show All >>

Drugs Related to temsirolimus

  1. Sirolimus (Rapamycin)
  2. everolimus
  3. bevacizumab
  4. sorafenib (BAY 43-9006)
  5. sunitinib (Sutent)
  6. Interferon-alpha (Interferon Alfa)
  7. temsirolimus
  8. Interferons
  9. Cisplatin (Platino)
  10. Protein-Tyrosine Kinases (Tyrosine Kinase)
Show All >>

Therapies Related to temsirolimus

  1. Drug Therapy (Chemotherapy)
  2. Heterologous Transplantation (Xenotransplantation)
  3. Castration
  4. Radiotherapy
  5. Aftercare (After-Treatment)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.